Which funds hold RGNT?

As of 2026-Q2, 2 institutional funds reported holding RGNT (REGENTIS BIOMATERIALS LTD) in SEC 13F filings, with a combined reported value of $48.65K.

How many shares of RGNT do institutions own?

13F filers reported 13.78K shares of RGNT, worth $48.65K in aggregate at the end of 2026-Q2.

Is institutional ownership of RGNT rising or falling?

Share counts moved +4026.3% versus the prior quarter — accumulation.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Home › Stocks › RGNT

RGNT — REGENTIS BIOMATERIALS LTD

Reported value held$118.83K

Funds holding (latest)3

SectorHealth Care

Funds holding (Q2 2026)2

Institutional value$48.65K · 13.78K sh

New / Add / Cut / Exit1 / 1 / 0 / 0

Top-5 / Top-10 concentration100.0% / 100.0%

Institutional holdings change Accumulating +4026.3% (+13.45K sh)

Institutional value change Up +4669.6%

As of Q2 2026, 2 SEC-registered investment managers reported holding RGNT (REGENTIS BIOMATERIALS LTD) in their latest 13F filings, with a combined reported value of $48.65K across 13.78K shares. That is +4026.3% by share count (+13.45K shares) versus the previous quarter, while reported value moved +4669.6%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.

Compared with the prior quarter, 1 opened new positions, 1 added to existing stakes. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.

RGNT is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Fund	Quarter	Shares	Value	Portfolio Weight	Change
Citadel Advisors history	Q4 2025	10.41K	$70.18K	0.00%	New
Renaissance Technologies history	Q2 2026	13.35K	$47.12K	0.00%	New
UBS Group AG history	Q2 2026	434	$1.53K	0.00%	Add

New Positions (Q2 2026)

Renaissance Technologies 13.35K sh · $47.12K

Fully Exited (vs previous quarter)

No tracked fund fully exited this quarter.

Fund Position History — shares by quarter (top 3 funds)

Fund	Q4 2025	Q1 2026	Q2 2026
Renaissance Technologies	—	—	13.35K
UBS Group AG	—	334	434
Citadel Advisors	10.41K	—	—

Download holders (CSV)